Modafinil

Modafinil is a 5.5–6.0/10 fit for people using cognition focus, energy, and mood as a measured experiment, not a belief-based staple. The best anchors are Caldwell JA et al. 2004, which reports pilot performance and mood study during extended wakefulness and relevant to sleep-deprivation rescue rather than rested daily enhancement, and Muller U et al. 2013, which reports healthy-volunteer study supporting a mixed cognitive profile and creativity trade-off rather than uniform enhancement. That gives Modafinil a real signal, but the report should stay narrow because responder fit, baseline status, and outcome tracking drive the practical value. Use Modafinil when the target is specific, measurable, and worth the tradeoff. Skip or stop Modafinil when the expected symptom, lab, or performance marker stays flat.

✅ Best for: Adults with diagnosed narcolepsy or idiopathic hypersomnia working with a sleep clinician; OSA patients with residual sleepiness after airway treatment; shift-work patients using modafinil as part of a circadian plan; and selective off-label users who need infrequent travel, jet lag, or sleep-debt rescue. Modafinil is also a fit for narrow, convergent work where wakefulness is the bottleneck and the dose can be taken early. The cleanest personal-use pattern is low-dose, intermittent, morning-only use with caffeine reduced or removed.

❌ Avoid if: You are pregnant, planning conception, or relying on hormonal contraception without backup; you have a history of serious drug rash, SJS/TEN, DRESS, mania, psychosis, uncontrolled anxiety, arrhythmia, structural heart disease, or stimulant sensitivity; you take MAOIs or complex CYP-interacting medication stacks; you are a tested athlete without anti-doping review; or you want daily motivation in place of sleep. Avoid chronic daily off-label nootropic use, unverified gray-market sourcing, pediatric use, and late-morning or afternoon dosing.